References
- Abbasian, C, Power, P. 2009. A case of aripiprazole and tardive dyskinesia. J Psychopharmacol Mar;23(2)214–5. Epub 2008 May 30.
- Casey D. Tardive dyskinesia and atypical antipsychotic drugs. Schizophr Res 1999; 35(Suppl)S61–66
- Casey D. Pathophysiology of antipsychotic drug-induced movement disorders. J Clin Psychiatry 2004; 65(Suppl 9)25–28
- Correll C, Schenk E. Tardive dyskinesia and new antipsychotics. Curr Opin Psychiatry 2008; 21(2)151–156
- Duggal H, Mendhekar D. Atypical antipsychotics, tardive dyskinesia, and D(2) receptors. Am J Psychiatry 2006; 163(8)1449–1450
- Fleischhacker W, Lemmens P, van Baelen B. A qualitative assessment of the neurological safety of antipsychotic drugs; an analysis of a risperidone database. Pharmacopsychiatry 2001; 34(3)104–110
- Kane JM. Tardive dyskinesia rates with atypical antipsychotics in adults: prevalence and incidence. J Clin Psychiatry 2004; 65(Suppl 9)16–20
- Kantrowitz JT, Srihari V, Tek. Resolution of tardive dyskinesia after addition of aripiprazole to haloperidol depot. J Clin Psychopharmacol 2007; 27(5)525–526
- Lim HK, Pae CU, Lee C, Lee. Tardive dystonic symptoms associated with aripiprazole treatment. Prog Neuropsychopharmacol Biol Psychiatry 2008; 32(2)589–590
- Lykouras L, Rizos E, Gournellis R. Aripiprazole in the treatment of tardive dyskinesia induced by other atypical antipsychotics. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31(7)1535–1536
- Miller del, D, Eudicone, JM, Pikalov, A, Kim. 2007. Comparative assessment of the incidence and severity of tardive dyskinesia in patients receiving aripiprazole or haloperidol for the treatment of schizophrenia: a post hoc analysis. J Clin Psychiatry, 68(12)1901–1906.
- Schooler NR, Kane JM. Research diagnoses for tardive dyskinesia. Arch Gen Psychiatry 1982; 39(4)486–487
- Sharma A, Ramaswamy S, Dewan VK. Resolution of ziprasidone-related tardive dyskinesia with a switch to aripiprazole. Prim Care Companion J Clin Psychiatry 2005; 7(1)36
- Soares-Weiser K, Fernandez HH. Tardive dyskinesia. Semin Neurol 2007; 27(2)159–169
- Tandon, R, Jibson, MD. 2001. Pharmacologic treatment of schizophrenia: what the future holds. CNS Spectr, 6(12):980–984, 986.
- Tarsy D, Baldessarini RJ. Epidemiology of tardive dyskinesia: is risk declining with modern antipsychotics?. Mov Disord 2006; 21(5)589–598